DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $203,577 | -11.5% | 767 | -14.0% | 0.09% | -15.2% |
| Q3 2022 | $230,000 | -9.1% | 892 | -10.5% | 0.10% | -2.8% |
| Q2 2022 | $253,000 | -15.7% | 997 | -2.4% | 0.11% | -0.9% |
| Q1 2022 | $300,000 | -15.0% | 1,022 | -4.7% | 0.11% | -8.4% |
| Q4 2021 | $353,000 | +1.4% | 1,072 | -6.1% | 0.12% | -4.0% |
| Q3 2021 | $348,000 | +3.6% | 1,142 | -8.8% | 0.12% | +13.8% |
| Q2 2021 | $336,000 | +10.5% | 1,252 | -7.4% | 0.11% | +6.9% |
| Q1 2021 | $304,000 | -15.1% | 1,352 | -16.1% | 0.10% | -16.4% |
| Q4 2020 | $358,000 | -27.2% | 1,612 | -29.5% | 0.12% | -33.7% |
| Q3 2020 | $492,000 | +14.7% | 2,287 | -5.7% | 0.18% | +7.6% |
| Q2 2020 | $429,000 | +15.6% | 2,425 | -9.4% | 0.17% | 0.0% |
| Q1 2020 | $371,000 | -26.2% | 2,678 | -18.3% | 0.17% | -11.9% |
| Q4 2019 | $503,000 | -46.0% | 3,279 | -49.1% | 0.19% | -48.8% |
| Q3 2019 | $931,000 | +19.4% | 6,445 | +18.1% | 0.38% | +16.3% |
| Q2 2019 | $780,000 | – | 5,457 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |